U.S. markets closed

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
9.27-0.05 (-0.54%)
At close: 04:00PM EDT
9.27 0.00 (0.00%)
After hours: 04:27PM EDT

Dyne Therapeutics, Inc.

1560 Trapelo Road
Waltham, MA 02451
United States
781 786 8230

Full Time Employees134

Key Executives

NameTitlePayExercisedYear Born
Mr. Joshua T. BrummCEO, Pres & Director946.5kN/A1978
Ms. Susanna Gatti High M.B.A.Chief Operating Officer655.5kN/A1968
Dr. Oxana Beskrovnaya Ph.D.Chief Scientific Officer631.08kN/A1962
Dr. Romesh Subramanian Ph.D.Co-Founder & AdvisorN/AN/A1965
Mr. Richard William Scalzo M.B.A.Sr. VP and Head of Fin. & Admin.N/AN/A1987
Mr. John Najim M.B.A.Chief Technical OfficerN/AN/AN/A
Ms. Amy ReillySr. VP and Head of Corp. Communications & Investor RelationsN/AN/A1974
Mr. Daniel WilsonSr. VP & Head of LegalN/AN/A1972
Ms. Kate MitchellVP & Head of HRN/AN/AN/A
Ms. Debra FeldmanChief Regulatory Affairs OfficerN/AN/A1971
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Dyne Therapeutics, Inc.’s ISS Governance QualityScore as of September 1, 2023 is 9. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.